COMMUNIQUÉS West-GlobeNewswire

Nicox : Nombre de droits de vote au 31 mars 2018
03/04/2018
Nicox SA Société anonyme au capital de 29 555 226 euros Siège social : DRAKKAR D 2405 route des Dolines 06560 Valbonne Sophia-Antipolis R.C.S. GRASSE 403.942.642 Le 3 avril 2018, PUBLICATION MENSUELLE DU NOMBRE D' [...]
Nicox: Number of voting rights as of March 28, 2018
03/04/2018
Nicox SA Société anonyme with a registered capital of € 29,555,226 Head Office: DRAKKAR D 2405 route des Dolines 06560 Valbonne Sophia-Antipolis R.C.S. GRASSE 403.942.642 On March 28, 2018, MONTHLY PUBLICATION OF THE [...]
Nicox : Nombre total de droits de vote au 28 mars 2018
03/04/2018
Nicox SA Société anonyme au capital de 29 555 226 euros Siège social : DRAKKAR D 2405 route des Dolines 06560 Valbonne Sophia-Antipolis R.C.S. GRASSE 403.942.642 Le 28 mars 2018, PUBLICATION MENSUELLE DU NOMBRE D' [...]
Nova Leap Health Corp. Announces Execution of Definitive Agreement to Acquire Home Care Services Business in Eastern Canada, Anticipates Significant Increase in Revenues
03/04/2018
NOT FOR DISSEMINATION IN THE UNITED STATES OR FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES HALIFAX, Nova Scotia, April 03, 2018 (GLOBE NEWSWIRE) -- NOVA LEAP HEALTH CORP. (TSXV:NLH) ("Nova Leap" or “the Company”) is [...]
Progressive Care Releases Investor Presentation
03/04/2018
MIAMI, April 03, 2018 (GLOBE NEWSWIRE) -- Progressive Care Inc. (OTCQB:RXMD), a healthcare services and technology company, announced that is has released its investor presentation for public view. The Company has [...]
Shire plc : Director/PDMR Shareholding
03/04/2018
Director/PDMR Shareholding April 3, 2018 - Shire plc (LSE: SHP, NASDAQ: SHPG) Notification of transactions by persons discharging managerial responsibilities 1. Details of the person discharging managerial [...]
Canada House Announces Third Quarter Fiscal 2018 Results
03/04/2018
Cash Position Improves to $10.9 million, up from $0.7 million as at April 30, 2017 Shareholders Equity improves to $8.2 million compared to a deficit of $1.2 million as at April 30, 2017 NOT FOR DISTRIBUTION TO U.S. [...]
Androvia LifeSciences Study Reveals New Evidence for Men Experiencing Fertility Problems
03/04/2018
Timing for Sperm Maturation and Capacitation Differs Dramatically in Men MOUNTAINSIDE, N.J., April 03, 2018 (GLOBE NEWSWIRE) -- Androvia LifeSciences , a company dedicated to the development of male fertility solutions [...]
Symphony Health’s New Enhanced Views Program Expands Evidence-Driven Insights
03/04/2018
Enhanced panel provides expanded insights across multiple information assets and offers new insight to patient activity and the treatment journey CONSHOHOCKEN, Pa., April 03, 2018 (GLOBE NEWSWIRE) -- Symphony Health , a [...]
Adamas Announces First Patient Enrolled in Phase 3 Trial of ADS-5102 in Multiple Sclerosis Patients with Walking Impairment
03/04/2018
EMERYVILLE, Calif., April 03, 2018 (GLOBE NEWSWIRE) -- Adamas Pharmaceuticals, Inc. (Nasdaq: ADMS ) today announced that the first patient has been enrolled in its pivotal Phase 3 clinical trial of ADS-5102 (amantadine [...]
WellDoc Announces Providence Health & Services’ Implementation of BlueStar® Digital Therapeutic in a Pilot Program for Individuals with Type 2 Diabetes
03/04/2018
COLUMBIA, Md., April 03, 2018 (GLOBE NEWSWIRE) -- Today, WellDoc ® announced a pilot program in the Providence Health & Services Oregon/SW Washington Region to examine the use of WellDoc’s BlueStar ® , an FDA- [...]
AXIM Biotech Reaches Preliminary Agreement for Distribution of CanChew and MedChew Products Throughout South Korea
03/04/2018
NEW YORK, April 03, 2018 (GLOBE NEWSWIRE) -- AXIM ® Biotechnologies, Inc . (AXIM ® Biotech) (OTCQB:AXIM), a world leader in cannabinoid research and development, today announced that it has entered into a Memo of [...]
Ceapro Announces Acceptance of Abstract for Presentation at the Nutrition 2018 Meeting
03/04/2018
EDMONTON, Alberta, April 03, 2018 (GLOBE NEWSWIRE) -- Ceapro Inc. (TSX-V: CZO ) (“Ceapro” or the “Company”), a growth-stage biotechnology company focused on the development and commercialization of active ingredients [...]
NewLink Genetics Announces Participation at The H.C. Wainwright Annual Global Life Sciences Conference
03/04/2018
AMES, Iowa, April 03, 2018 (GLOBE NEWSWIRE) -- NewLink Genetics Corporation (NASDAQ: NLNK ) announced today it will present at the H. C. Wainwright Annual Global Life Sciences Conference. The conference is being held on [...]
ProLynx extends lead in half-life extension platform technology – Shows primary deuterium kinetic isotope effects prolong drug release and polymer biodegradation in a drug delivery system
03/04/2018
SAN FRANCISCO, April 03, 2018 (GLOBE NEWSWIRE) -- ProLynx announced today the publication of a paper demonstrating its leading capabilities to exploit primary deuterium kinetic isotope effects (1°DKIEs) for prolonging [...]
Q-Centrix Solution Among First to Be Certified for CathPCI v5 Reporting
03/04/2018
With the new certification, Q-Centrix continues to lead the way in providing comprehensive solutions for participation in major cardiac-care registries Chicago, April 03, 2018 (GLOBE NEWSWIRE) -- Q-Centrix adds [...]
Wildflower Secures $720,000 Purchase Order
03/04/2018
VANCOUVER, British Columbia, April 03, 2018 (GLOBE NEWSWIRE) -- Wildflower Marijuana Inc. (CSE:SUN) (FWB:RSP) (“Wildflower” or the "Company") has received its first purchase order pursuant to the recently announced [...]
CURE Pharmaceutical Reports Strong Progress and Sets Growth Roadmap for Remainder of Year
03/04/2018
OXNARD, Calif., April 03, 2018 (GLOBE NEWSWIRE) -- CURE Pharmaceutical (OTC:CURR), an innovative drug delivery company, today reported the company’s Q1 2018 accomplishments. The company strengthened its leadership team [...]
UroGen Pharma Announces Presentation of Results from Interim Analysis of Pivotal Phase 3 OLYMPUS Trial of UGN-101 (MitoGel™) for Non-Surgical Treatment of Upper Tract Urothelial Cancer (UTUC)
03/04/2018
RA’ANANA, Israel and NEW YORK, April 03, 2018 (GLOBE NEWSWIRE) -- UroGen Pharma Ltd. (Nasdaq: URGN ), a clinical-stage biopharmaceutical company developing treatments to address unmet needs in the field of urology, with [...]

Pages